Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guzhi Xiaotong granules in cervical spondylotic radiculopathy
CTR20150042Phase 3Active
- Sponsor
- Beijing Zhaohan Pharmaceutical Technology Research Institute
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Guzhi Xiaotong Granules in cervical spondylotic radiculopathy (CSR), sponsored by Beijing Zhaohan Pharmaceutical Technology Research Institute. Started Jan 2015; status: active.
02
Drugs
Guzhi Xiaotong Granules
03
Conditions
cervical spondylotic radiculopathy (CSR)
Beyond the preview
Go deeper on CTR20150042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150042.